ADCT vs REGN: Which Stock is Better?
Side-by-side comparison of ADC Therapeutics SA and Regeneron Pharmaceuticals Inc in 2026
ADCT
ADC Therapeutics SA
$3.52
REGN
Regeneron Pharmaceuticals Inc
$733.78
Key Metrics Comparison
| Metric | ADCT | REGN | Winner |
|---|---|---|---|
| Market Cap | $436.05M | $77.69B | REGN |
| P/E Ratio | N/A | 17.57 | REGN |
| EPS (TTM) | $N/A | $41.71 | REGN |
| Revenue Growth | -0.1% | 0.0% | REGN |
| Gross Margin | -57.4% | 45.8% | REGN |
Analyze ADCT
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADCT or REGN a better investment?
Comparing ADCT and REGN: ADC Therapeutics SA has a market cap of $436.05M while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADCT and REGN?
ADCT (ADC Therapeutics SA) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADCT or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADCT or REGN?
REGN has higher revenue growth at 0.0% vs -0.1% for ADCT.
Which company is more profitable: ADCT or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to -57.4% for ADCT.
Which is the larger company: ADCT or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $436.05M for ADCT.
Should I buy ADCT or REGN in 2026?
Both ADCT and REGN have investment merit. ADCT trades at $3.52 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADCT and REGN stock?
Key differences: Market Cap ($436.05M vs $77.69B), P/E Ratio (N/A vs 17.6x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (-57.4% vs 45.8%).